Collegium Pharmaceutical, Inc. Operating Leases, Future Minimum Payments, Due in Four Years
Collegium Pharmaceutical, Inc. (COLL) had Operating Leases, Future Minimum Payments, Due in Four Years of $1.30 million as of 2018-12-31, per its 10-K filed 2020-02-27.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInFourYears · last filed 2020-02-27
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.30M.
- 2017-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $1.30M.
- 2016-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $164.00K.
- 2015-12-31: Operating Leases, Future Minimum Payments, Due in Four Years $241.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Four Years |
|---|---|
| 2018-12-31 | $1.30M 10-K · filed 2020-02-27 |
| 2017-12-31 | $1.30M 10-K · filed 2019-02-27 |
| 2016-12-31 | $164.00K 10-K · filed 2017-03-10 |
| 2015-12-31 | $241.00K 10-K · filed 2016-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |